Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-10-01

Clinical Trial Update: The Effect of Telephone Counseling on the Compliance and Satisfaction for Advanced HCC Patients Receiving Sorafenib [NA]

View source ↗

Summary

This document provides a clinical-trial update on whether telephone counseling improves compliance and satisfaction in patients with advanced hepatocellular car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nexavar (Sorafenib)

Snippet

Sponsor: Asan Medical Center | Conditions: Hepatocellular Carcinoma | NA | Status: UNKNOWN